IE
AUPH icon

Israel Englander’s Aurinia Pharmaceuticals AUPH Stock Holding History

Israel Englander’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,000
Closed -$664K – 6762
2021
Q3 		$664K Buy
+30,000
New +$476K ﹤0.01% 5075

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Israel Englander's AUPH Position: Q2 2026 in Review

Israel Englander increased its Aurinia Pharmaceuticals (AUPH) stake by 109% in Q2 2026, buying an estimated $2.03M and bringing the position to 244,302 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

Israel Englander first reported a position in AUPH in Q1 2015 and has held it in 37 quarters since. The position peaked at $39.4M in Q4 2019. 280 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Israel Englander held 244,302 shares of Aurinia Pharmaceuticals worth $4.15M as of Q2 2026.
  • Israel Englander bought 127,133 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $2.03M.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3171 holding.
  • Israel Englander first reported a position in Aurinia Pharmaceuticals in Q1 2015 and has held it in 37 quarters since.
  • Israel Englander's Aurinia Pharmaceuticals position peaked at $39.4M in Q4 2019.
  • 280 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.